The primary benefit of anastrozole is its ability to reduce the risk of breast cancer recurrence in postmenopausal women. Clinical trials have shown that anastrozole is more effective than tamoxifen, another hormone therapy, in preventing cancer recurrence. Additionally, anastrozole has been found to reduce the risk of developing new cancers in the opposite breast.